Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes Leo,
Very ripe for the picking! Hopefully with all the positive steps, the valuation will go up as it should. My belief is that the company has been under negotiations all along and these steps are either part of the stipulations of the offer, or Jenny's way of asking can we get more if we do...this, this, and this?
HOPEFULLY GETTING MULTIPLE OFFERS! Those in corporate world know when a company is entertaining offers.
Time will tell, and that time is rapidly approaching! Not much else left to do but take a deal or raise capital.
I think deal!
IMHO
Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that physicians in Europe have performed the 500th PHP Therapy® treatment using the company’s Hepatic CHEMOSAT® Delivery System (CHEMOSAT). CHEMOSAT was launched in select European markets in 2012, and physicians there have used it to treat a wide variety of cancers of the liver.
Jennifer K. Simpson, Ph.D., President and CEO of Delcath Systems, said, “this is a meaningful milestone for Delcath, one that speaks to the belief physicians in Europe have developed in our product and this therapy for certain types of liver cancers. Our commercialization efforts in Europe have established a considerable body of published and presented research data that demonstrates the safety and efficacy of this therapy in appropriate patients. Further, Dutch Health Authorities recently included CHEMOSAT treatment in their published guidelines for ocular melanoma liver metastases, a step toward potential reimbursement coverage of CHEMOSAT in the Dutch market. We continue to leverage this experience to validate the safety and efficacy of the melphalan/Hepatic Delivery System (CHEMOSAT) in our clinical trials.”
Percutaneous Hepatic Perfusion (PHP) Therapy with Melphalan/HDS was developed by Delcath Systems as a targeted, whole organ therapy for the liver. It is commercially available as a device in Europe, where it is marketed as CHEMOSAT®. The system has not been approved by the U.S. Food and Drug Administration, and is undergoing Phase 3 clinical testing in the U.S. as an investigational product.
Yes, from 240 to 200 patients only!
NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the independent Data Safety Monitoring Board (DSMB) of the Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma has completed its pre-specified review of safety data for treated patients in the trial. The DSMB has recommended that the study continue without modification.
The FOCUS Trial is evaluating the efficacy, safety and pharmacokinetics of Melphalan/HDS versus best alternative standard of care in 240 patients with metastatic ocular melanoma (OM). The primary objective of the study is a comparison of overall survival between the Melphalan/HDS treatment arm and best alternative care arm comprised of selected therapies; secondary objectives include overall progression-free survival and objective response rate, each as determined by the Investigator, while exploratory objectives include progression-free survival, objective response rate, hepatic progression free survival and hepatic objective response rate all as determined by blinded Independent Central Review, and quality of life measures. The FOCUS Trial is being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) to support marketing approval in the U.S.
“The DSMB’s recommendation to proceed without modification with the FOCUS Trial as planned confirms our own observations of the safety profile of PHP therapy based on prior research and our commercial experience with CHEMOSAT in Europe,” said Jennifer K. Simpson, Ph.D., MSN, CRNP President and CEO of Delcath. “Importantly, this initial independent evaluation of the safety profile of melphalan/HDS used the Generation Two filter configuration of the device and the current version of the procedure protocol, and so provides confidence in both our product and procedure. Given that safety concerns with the previous generation product and procedure were the primary issue in the FDA’s previous assessment, we are pleased to have successfully passed this important milestone.
Updated trial information on the clinical trials.gov website
Just checking in on the trials, and I see they also updated the trial info as of January 31, 2018
If I am not mistaken, the original required number of participants were 240, and now it reflects only a requirement of 200 participants. That is also great news for the company, and a huge positive when it comes to getting the trial done and FDA approval!
Sam, were you not a huge promoter of a buyout just a few months back? Anything can happen here, and you know it. Sometimes it is hard to speculate, but admit...Buyout, partnerships, and mergers are all possible.
IMHO
Very well thought out plan. Thanks for sharing.
Courtesy of Rap...As of this morning MAXM/CDEL each have a max of 6.06M shares to sell.
Theoretically no more than 12M combined remain.
4.9% x 123,700,000. That’s my interpretation of the PR.
Thoughts?
My belief is that we will close Green again today!
The Hudson Bay selling is almost gone...very few shares left to sell at these prices. Unfortunately the float is pretty high right now, so it is going to take a lot of accumulation to start driving the PPS. This Stock is way oversold and is coiled and ready to strike upwards! The company is way undervalued and the market cap is a joke right now. With their proven technology I can easily see 200M-500M market plus...
With the balance sheets cleared up, toxic financing completed, patents free and clear, good safety data from Independent Monitoring Committee, the company is well poised for offers of buyouts, partnerships, and mergers. Anything can happen, and I am positive they are receiving offers at this time. If it is lucrative enough, we will hear about it soon...if not, Delcath always has the S-1 offering in their back pocket to raise funds to get through the pivotal phase 3. With FDA approval, the sky is the limit!
GOOD LUCK EVERYONE, NO MATTER HOW YOU TRADE
IMHO
Delcath Announces Satisfaction of 2016 Convertible Note
GlobeNewswireFebruary 1, 2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has satisfied all of its obligations under the privately placed senior secured convertible notes issued to two institutional investors in June 2016. On December 28, 2017, Delcath entered into exchange agreements with two institutional investors pursuant to which those investors were issued, in exchange for satisfaction in full of those notes, shares of its common stock (or rights to receive common stock to the extent such issuance of Shares would otherwise result in the beneficial ownership by any such investor of more than 4.9% or 9.9% of our issued and outstanding stock), as applicable, in an aggregate of 123,708,735 shares of our common stock. As of January 25, 2018, all of the Rights were exercised, and neither investor owns more than 4.9% of the issued and outstanding shares of Delcath’s common stock.
Totally agree and I feel your pain! Although I was not in pre reverse split, I do have more in the ante here than I otherwise would have put into the pot. I like Rap feel that this company is way undervalued. Lots of good things are finally happening, and it appears that the "Near-Death" of the company experience that Jenny and the BOD felt may have actually lit a fire under them! Either way, I'm along for the ride!
Best of luck H2004 Buddy!
IMHO
Make no mistake, Rap is not gone! He is right here with us chomping at the bit to say something quick witted and clever! Unfortunately he has been temporarily exiled from the island...but don't lose any sleep, for he will be back!
In the mean time, we get the constant harassment of the bashers who never get banned for their irresponsible and misplaced statements.
Green today, GREEN into the future!
Rise up DCTH, time to make some noise!IMHO
Welcome aboard!
Listen to all, some are good posters with good DD, others are good bashes filled with one liners! Be weary of those posting false statements as facts with no evidence!
I believe you will be rewarded for your investment or trade. Which ever you are in for.
Best of luck!
IMHO
Ive actually received replies to a couple of emails...
I submitted to: investorrelations@delcath.com
I have received responses from:
Tom Johnson
And:
Leslie Callahan
And:
John Shea
Share your experiences! Be nice, or they probably won't respond...
Good Luck!
IMHO
Only all the positive steps the company has been making over ththe past couple of months...
Past performance should not be used as a measuring device for future results!
Best of luck my friend!
IMHO
Confirmed with IR on Patents.
It is only a paperwork shuffle until the USPTO Website is updated.
DCTH Patents are free and clear!
Gonna be waiting a while!
IMHO
Must be more Hudson Bay note holders selling today...they are the only ones to make a profit at that level. why else would anyone in their "investment" frame of mind sell at .03 when .04 was a reality just yesterday? The selling will cease, and the accumulation will resume. Good company with a great futuristic outlook. Good fundamentals...finally, and way oversold! RSI can't get any lower....only one way I see it...UP
IMHO
No worries
Original S-1 is just that...it has been amended several times. Hence the /A added at the end each time thereafter. The company has the rights to amend as many times as they see fit. Until they actually file the S-1/A, with actual prices, it doesn't go into effect.
IMHO
But as you point out so often Sam is that it is "possible" and "could" happen. Us positive posters point out that a buy out could possibly happen, a partnership could possibly happen, a merger could possibly happen. You like to concentrate on a huge share increase is more likely the case? Either are possibilities! Don't be a negative Nancy and realize that the S-1 was submitted way back in October of last year and still has not taken effect...and may never.
IMHO
H2004, we know it wasn't you that said it, only replying how ludicrous it was for the original poster to imply that it would ever hit ,001. Lol. Better chance of seeing 1,00 first. So, "The Great Person"...will be waiting for quite a while!
I'm on your side there little buddy!
IMHO
That poster is what is ridiculous! No way will this ever go that low. It will hit 1.00 before it would ever HIT .001. Lol
Best he keep waiting and watching from the sidelines!
IMHO
Ready to wait a long time I see....posted today that you will be waiting? Lets hear from you again in say...two or three months when you buy your shares, until then, what could you possibly contribute to this message board other than you are wanting to buy but have not because you can't afford today's prices? Speculate if you will, but be realistic!
Best of luck Great Guy!
IMHO
Delivery of shares today! Could be very interesting around here in a week or so when the announcements are made. Makes sense to have this finalized before the company releases it's Annual report, I believe due in March.
Thanks for Posting Leo!
IHMO
Gonna be quiet around here for the next week or two without RAPTURE's great zingers and wisdom! Looks like he may have been snagged by the long arm of the IHUB law? restricted posting...which is very unfortunate because those of the likes of the constant bashers...(Dr not pepper, Trump-etier, and Of-fery), are not receiving any punishment and are free to call names and bash as much as they want. Seems kind of unfair?
Anyway, RAP, we've got your back brother! Hurry back from your vacation!
IMHO
Sam,
the original S-1 came out back in October, the fact that a pricing has not been mentioned yet says that they are not ready to execute yet. Amending the S-1 only gives them rights to keep in on the table should they need to execute expeditiously. Just like a vote for future possible share increases....they are "Possible". Meaning could happen if/when the company decides it is necessary. My guess: If DCTH receives a lucrative offer from another company, (ATNX or not), they will consider the offer. If they don't like the offer, the S-1A will come into effect. For all we/you know, the company could be under a NDA at this time...maybe cleaning up the balance sheets and freeing up the patents was part of the plan to make an offer binding...again, SPECULATION!
Where do you get the idea that they are...
Athenex has way more in funding to conduct more trials than Delcath, so I could quite easily see this transaction happening. If it does in fact become a merger rather than buy out or partnership, I could see ATNX handing out say 1 share for every 300 DCTH shares you own? Complete speculation on my part, but I have seen it work out in the past.
IMHO
Absolutely I'm in! Bought a few more today at .035. Didn't think I would get any more, but just too tempting! Nearing my 1M share max now. Time to let it ride and see where we end up. I'm very bullish in this and have quite a bit of coin in the game! Both yours and Rap's posts are welcoming in the sea of saviors and so called shorters. Time will tell in the not so distant future, and I will be right here waiting and watching! A buyout of say 250-500M sounds very lucrative, but for an effective cancer treatment...that may be used to treat other parts of the body as well? What would be a "good" price for a bigger player to scoop this one up?
IMHO
Lots of sellers this morning on that little jump to .04. Some say weak Hands, some say profit taking? Either way, I am sure just as sunshine there were several 100's of thousands taken between .025 and .035 that are getting dumped today. Hope they made a nice profit...enough to be able to say thank you. I believe the fun has only begun...once the "Canadian Gang" and the saviors get theirs, we will start to move up again. Just too many positives and coincidences to stay low for long. Currently the company controls its own destiny...
no more toxic financing
Patent Liens are paid
Positive Independent Safety Data
Relaxed trial procedures from the FDA
Phase 3 past midterm, and should wrap up within a year. (could have enough positive results to finish early?)
ATNX looking for acquisitions....specializing in cancers?
Buyout or partnership could be behind any corner?
Already proven in Europe and blessed by the EU...Just waiting on FDA which appears eminent?
Lots of stars lining up. Selling now could be the right move....but this could also be the time to accumulate as well?
IMHO
Best of luck everyone!
The serious question is...
Why is Trompete still here?
IMHO
Just a suggestion here...you have said like ten times that you are worried about increasing authorized shares. And like 10 people have pointed out that is not the case. Right now you are only clouding the judgment of other investors on this board. You really have two choices...wait it out and see what happens, or sell and move on. Constantly repeating the same thing does nothing for anyone.
IMHO
Good Luck
Sam, I'm not by any means a pumper, and the positives I mention are just that....POSITIVES! My point is that the company has come a long way just in the course of the new year. Why the sudden chain of events? Do you honestly know? I don't....only guesses here as with everyone else on this board. And the last positive of Patents released and dumping complete was new...just to point out. It posted after close yesterday. I don't make assumptions, and I don't post crap ever...no matter how badly I feel about certain tickers. I have lost 10's of thousands on bad picks, and I have also made 10's of thousands. I currently hold just under 1M in DCTH SHARES, and my price is at .0394 so as you can see, I am quite invested here too.
Please don't try to one up all my posts, I only post what I know, and what I see as possibilities. And, I always post IMHO. Some here are new to the board and don't have all the information that you and I have. Helping other investors is something I try to do for I know how hard it was when I first started.
As always, best of luck!
IMHO
I would expect a company letter to shareholders in the near future providing an outlook to 2018. I check the USPTO website as well as the Clinicaltrials.gov website daily to watch for changes. Rest assured that big things are happening here behind the scenes. Not exactly sure what it is, and don't want to speculate, updating the clinical trials website in January was huge...getting the positive review from the Independent Safety Monitoring Committee also huge...clearing the IOU's also huge...getting full control of their 15 patents being held ransome by Hudson Bay...YUGE!
This opens up the door to many possibilities. The newest offering of up to 250 million shares just shows they are ready to take the next step to make this company great again! It does take dollars to fund these trials, so it is a necessary evil....
But what I point out is that the company is free and clear for any offers that come their way! Whether that be partnership or outright buyout remains to be seen. We already know this is approved all over Europe, and I'm sure will be in other continents too in the near future. With so many positive treatments already, reimbursement is going to be growing in the future too. Look for positive quarter over quarter outlooks, and greater interest in bigger Pharma/Medical entities.
What would J&J or similar pay for a proven cancer treatment???
JMHO
Best of luck!
Great pick! Love it!
Poor Mortimer...Buy those oranges!
The upside here is huge, I plan to grab a few more in the coming weeks as well. My thought was that it would dip to .50 at some point with the pricing of the warrants. Who knows, maybe it will hold and this will actually move positive in anticipation of the PE results. Either way, I have enough shares at this point to make a substantial gain should we have good results....but would love to pick up another 50k at .40 or below before this takes off. In my honest opinion, it's a matter of when, not if this takes off! Best of luck
IMHO
Was able to pick up another 10K at .55 today...figures :(
Can't ever time these dips can we.
IMHO
And one may just wear a hat to cover their cold bald head?
IMHO
Congrats on the third child!
I'm in SanDiego...count me in too if this works out in our favor. Was just in LA this past weekend!
Let's see a DCTH 33-bagger from here! Take a dollar a share buy out!
Best of luck
I find it very strange that I have a GTC order in at .555 for another 10K and it did not get filled?
Any ideas?
I too believe that the P3 data will be good. I just went and looked at the past Mono studies again, and it looks like the viral load dropped significantly on each of the three varied doses significantly enough to show the 70% they are looking for the combo data. Granted it was only for 34 patients and 10 on placebo. Although I'm not sure how it will react with the other HAART combo drugs that it is paired with. I am more curious where the mono data will be read out...that one could erase all the HAART drugs for good, and present CYDY with a 100B payout! Just my two cents.
IMHO
I thought "Pigs get Fat"?
It is possible that DCTH can make a huge bounce from these levels as soon as the Hudson Bay deal is cleared and they finish dumping the 123 mil shares of convertible debt. Only time will tell my friend.
I like the odds and am getting closer to my 1mil goal here!
IMHO
Thanks Yianni, if it hits .02, I'll buy another 500,000 shares!
Between you, Ofri, and the goood Dr, I just may get my million shares!
IMHO